BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15276925)

  • 21. How Nordic Countries Enforce Impaired Driving Legislation.
    Jones AW
    Forensic Sci Rev; 2022 Jul; 34(2):131-143. PubMed ID: 35932486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in state drug testing and reporting by driver type in U.S. fatal traffic crashes.
    Slater ME; Castle IJ; Logan BK; Hingson RW
    Accid Anal Prev; 2016 Jul; 92():122-9. PubMed ID: 27060753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Driving under the influence of drugs and alcohol in Salzburg and Upper Austria during the years 2003-2007.
    Keller T; Keller A; Tutsch-Bauer E; Monticelli F
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S98-9. PubMed ID: 19282219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The frequency of drugs among Danish drivers before and after the introduction of fixed concentration limits.
    Steentoft A; Simonsen KW; Linnet K
    Traffic Inj Prev; 2010 Aug; 11(4):329-33. PubMed ID: 20730679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Referrals for psychiatric examination of driving ability - a comparison of illicit drugs and alcohol].
    Haberfellner EM
    Neuropsychiatr; 2008; 22(2):137-42. PubMed ID: 18606117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
    Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
    Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mirage of impairing drug concentration thresholds: a rationale for zero tolerance per se driving under the influence of drugs laws.
    Reisfield GM; Goldberger BA; Gold MS; DuPont RL
    J Anal Toxicol; 2012 Jun; 36(5):353-6. PubMed ID: 22582272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions.
    Kelly E; Darke S; Ross J
    Drug Alcohol Rev; 2004 Sep; 23(3):319-44. PubMed ID: 15370012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs in injured drivers in Denmark.
    Bernhoft IM; Steentoft A; Johansen SS; Klitgaard NA; Larsen LB; Hansen LB
    Forensic Sci Int; 2005 Jun; 150(2-3):181-9. PubMed ID: 15944058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of fitness to drive in correlation with narcotic and psychotropic drug use. Epidemiologic study in Verona].
    Bertaso A; Pascali JP; Liotta E; Polettini A
    G Ital Med Lav Ergon; 2011; 33(2):125-33. PubMed ID: 21796920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
    Gjerde H; Normann PT; Christophersen AS; Mørland J
    Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and trends of drugged driving in Canada.
    Robertson RD; Mainegra Hing M; Pashley CR; Brown SW; Vanlaar WGM
    Accid Anal Prev; 2017 Feb; 99(Pt A):236-241. PubMed ID: 27984814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is law enforcement of drug-impaired driving cost-efficient? An explorative study of a methodology for cost-benefit analysis.
    Veisten K; Houwing S; Mathijssen MP; Akhtar J
    Int J Drug Policy; 2013 Mar; 24(2):122-34. PubMed ID: 23127668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
    Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
    Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Socio-economic determinants of drugged driving--a register-based study.
    Karjalainen K; Lintonen T; Impinen A; Lillsunde P; Mäkelä P; Rahkonen O; Haukka J; Ostamo A
    Addiction; 2011 Aug; 106(8):1448-59. PubMed ID: 21375644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
    Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
    Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Accidents and illicit drugs].
    Mura P
    Bull Acad Natl Med; 2002; 186(2):345-57. PubMed ID: 12145842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Driving under the influence of drugs: Prevalence in road traffic accidents in Italy and considerations on per se limits legislation.
    Favretto D; Visentin S; Stocchero G; Vogliardi S; Snenghi R; Montisci M
    Traffic Inj Prev; 2018; 19(8):786-793. PubMed ID: 30024768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of medicinal drugs in suspected impaired drivers and a comparison with the use in the general Dutch population.
    Bezemer KD; Smink BE; van Maanen R; Verschraagen M; de Gier JJ
    Forensic Sci Int; 2014 Aug; 241():203-11. PubMed ID: 24973726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.